Bausch + Lomb shares tumble as Q1 earnings miss expectations

Published 30/04/2025, 13:48
Bausch + Lomb shares tumble as Q1 earnings miss expectations

Investing.com -- Bausch + Lomb Corporation (NYSE:BLCO) saw its shares plunge 10.4% after the eye health company reported first-quarter earnings that fell short of analyst estimates, despite revenue growth.

The company posted an adjusted loss per share of $0.07 for Q1 2025, missing the consensus estimate of $0.02 earnings per share. Revenue came in at $1.14 billion, slightly below expectations of $1.15 billion but up 3% YoY and 5% on a constant currency basis.

Bausch + Lomb’s Vision Care segment, its largest by revenue, grew 3% to $656 million, driven by increased sales of daily contact lenses and over-the-counter eye care products. The Surgical segment saw 9% growth to $214 million, while Pharmaceuticals revenue remained flat at $267 million.

"Our core business is performing well, and we remain focused on positioning the company for long-term, profitable growth," said CEO Brent Saunders.

However, the company reported a GAAP net loss of $212 million for the quarter, widening from a $167 million loss in Q1 2024. Adjusted EBITDA excluding acquired IPR&D fell to $126 million from $180 million a year ago.

Bausch + Lomb updated its full-year 2025 guidance to reflect the estimated one-time impact of a voluntary recall of certain intraocular lenses. It now expects revenue of $5.0-$5.1 billion, up from its previous forecast of $4.95-$5.05 billion.

The sharp stock decline suggests investors were disappointed by the earnings miss and lowered profitability outlook, despite the raised revenue guidance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.